Trade this between 9:30 and 10:45 am EST
July 2, 2026 Vertiv Is Up 73% in 2026. Now Comes the Hard Part. Q2...
July 2, 2026 Vertiv Is Up 73% in 2026. Now Comes the Hard Part. Q2...
Record revenue, 85% growth, and a raised outlook — yet the stock keeps sliding.
ADP missed. Vanguard's data is worse. The Fed has nowhere to go.
The fastest-growing corner of global finance is hitting its first real stress test.
Manufacturing just hit a 4-year high. The S&P 500 barely noticed.
XLV is leading, but not every part of healthcare is going the same direction.
Oil prices are falling. The second-order winners are still being ignored.
Four years of trucking pain may be ending. The pricing cycle that follows could be sharper than anyone expects.
Q4 earnings drop June 30. Here is what traders actually need to watch.
A kidney disease drug with Breakthrough Therapy status is 11 days from an FDA decision.